Ganirelix Acetate / Fyremadel

Ganirelix Acetate / Fyremadel is a gonadotropin releasing hormone with antagonistic (blocking) activity. It is indicated for the inhibition of premature LH (luteinizing hormone) surges in women undergoing controlled ovarian hyperstimulation. Ganirelix Acetate / Fyremadel is available as a prefilled syringe containing 250mcg/0.5ml.

Medication Information

Prescribing Information